Aparna R. Parikh
0000-0002-5245-7841
Publication & Citation Trends
Publications
0 total
A phase 2 randomized study comparing telisotuzumab adizutecan monotherapy with standard of care in patients with post-adjuvant circulating tumor DNA-positive colorectal cancer.
Cited by 0
Semantic Scholar
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program.
Cited by 1
Semantic Scholar
Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators
Cited by 1
Semantic Scholar
Microsimulation model to identify suboptimal recurrence detection in patients with colorectal cancer following the current standard of care
Cited by 0
Semantic Scholar
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors.
Cited by 2
Semantic Scholar
Tolerability and outcomes after neoadjuvant and definitive radiation of elderly patients with localized pancreatic cancer.
Cited by 0
Semantic Scholar
Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Cited by 0
Semantic Scholar
A phase 1/2 study of revumenib in patients (pts) with advanced colorectal cancer (CRC) and other solid tumors.
Cited by 0
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(168)
Cancer Genomics and Diagnostics
(142)
Immunotherapy and Immune Responses
(130)
vaccines and immunoinformatics approaches
(111)
Viral-associated cancers and disorders
(95)
Affiliations
Boston University
Brigham and Women's Hospital
National Institutes of Health
Barnes-Jewish Hospital
City Of Hope National Medical Center